|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales (exclusive of depreciation shown separately below) | |||||
| Selling, general and administrative expenses | |||||
| Depreciation | |||||
| Asset impairment | |||||
| Gain on sale of building | |||||
| Gain on insurance | |||||
| Income (loss) from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Income (loss) before income taxes | |||||
| Income tax (expense) benefit | |||||
| Net income (loss) | |||||
| Basic net income (loss) per common share | |||||
| Diluted net income (loss) per common share | |||||
| Weighted average number of shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
